Announcing a medical research study for advanced hereditary breast cancer.

Not just for you, for them.

Men and women aged 18 years or older who have advanced breast cancer due to a BRCA1 or BRCA2 gene mutation are invited to see if they may qualify for the Brocade Study. The purpose of this medical research study is to determine the safety and effectiveness of the investigational medication Veliparib (a PARP-inhibitor) in combination with chemotherapy in patients with metastatic or locally recurrent breast cancer.

Each individual will be evaluated to determine his or her eligibility. Those who qualify will receive chemotherapy in combination with either the investigational medication Veliparib or an inactive placebo, BRCA-related testing, study-related medical exams, and lab tests at no charge. Compensation for time and travel may also be available.

Find a participating oncologist.

To see if you may qualify for the Brocade Study, enter your zip code below or click on the map to find the participating oncologist(s) nearest you.

View full list of locations by state

View international locations

Active Site  
Active Site Location
  Future Site  
Future Site Location